The DOI matches its Crossref record; 150 of the 150 references it cites were found in a registry or an index.
The Extracellular Matrix and Pancreatic Cancer: A Complex Relationship
Open accessAbstract
Pancreatic ductal adenocarcinoma (PDAC) has an extraordinarily dense fibrotic stroma that impedes tumor perfusion and delivery of anticancer drugs. Since the extracellular matrix (ECM) comprises the bulk of the stroma, it is primarily responsible for the increased interstitial tissue pressure and stiff mechanical properties of the stroma. Besides its mechanical influence, the ECM provides important biochemical and physical cues that promote survival, proliferation, and metastasis. By serving as a nutritional source, the ECM also enables PDAC cells to survive under the nutrient-poor conditions. While therapeutic strategies using stroma-depleting drugs have yielded disappointing results, an increasing body of research indicates the ECM may offer a variety of potential therapeutic targets. As preclinical studies of ECM-targeted drugs have shown promising effects, a number of clinical trials are currently investigating agents with the potential to advance the future treatment of PDAC. Thus, the present review seeks to give an overview of the complex relationship between the ECM and PDAC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309
RetractedChemotherapy and radiotherapy for inoperable advanced pancreatic cancer
Yip, D., Karapetis, C., Strickland, A., Steer, C. B., & Goldstein, D. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002093.pub2 · Cited by 160
RetractedSiegel, R., Naishadham, D., & Jemal, A. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20138 · Cited by 10,679
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Conroy, T., Desseigne, F., Ychou, M., Bouché, O., Guimbaud, R., Bécouarn, Y., Adenis, A., Raoul, J.-L., Gourgou-Bourgade, S., de la Fouchardière, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011923 · Cited by 7,810
Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
Rahib, L., Smith, B. D., Aizenberg, R., Rosenzweig, A. B., Fleshman, J. M., & Matrisian, L. M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0155 · Cited by 7,094
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Von Hoff, D. D., Ervin, T., Arena, F. P., Chiorean, E. G., Infante, J., Moore, M., Seay, T., Tjulandin, S. A., Ma, W. W., Saleh, M. N., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1304369 · Cited by 6,712 · cited 2×
“However, only roughly one quarter to one-third of patients with metastatic disease responds to these therapies [4,7], and none of the currently available treatment options provides long-term survival for the average patient [7].”
BackgroundRole of YAP/TAZ in mechanotransduction
Dupont, S., Morsut, L., Aragona, M., Enzo, E., Giulitti, S., Cordenonsi, M., Zanconato, F., Le Digabel, J., Forcato, M., Bicciato, S., et al. (2011) · Nature · doi:10.1038/nature10137 · Cited by 5,979
Remodelling the extracellular matrix in development and disease
Bonnans, C., Chou, J., & Werb, Z. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3904 · Cited by 4,367 · cited 2×
“There are 23 MMPs, each with specific targets within the ECM, but collectively MMPs degrade all structural components of the ECM [89].”
BackgroundForner, A., Llovet, J. M., & Bruix, J. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61347-0 · Cited by 4,022
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969
Tensional homeostasis and the malignant phenotype
Paszek, M. J., Zahir, N., Johnson, K. R., Lakins, J. N., Rozenberg, G. I., Gefen, A., Reinhart-King, C. A., Margulies, S. S., Dembo, M., Boettiger, D., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.08.010 · Cited by 3,941
Giancotti, F. G., & Ruoslahti, E. (1999) · Science · doi:10.1126/science.285.5430.1028 · Cited by 3,869 · cited 1×
“Similar to collagens, fibronectin binds to integrin receptors (α5β1), thereby activating the FAK pathway [109].”
BackgroundThe Extracellular Matrix: Not Just Pretty Fibrils
Hynes, R. O. (2009) · Science · doi:10.1126/science.1176009 · Cited by 3,527
Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
Glycosylation in cancer: mechanisms and clinical implications
Pinho, S. S., & Reis, C. A. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3982 · Cited by 3,083
Clarke, M. F., Dick, J. E., Dirks, P. B., Eaves, C. J., Jamieson, C. H. M., Jones, D. L., Visvader, J., Weissman, I. L., & Wahl, G. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-3126 · Cited by 3,051
Glycosylation in Cellular Mechanisms of Health and Disease
Ohtsubo, K., & Marth, J. D. (2006) · Cell · doi:10.1016/j.cell.2006.08.019 · Cited by 2,788
Özdemir, B. C., Pentcheva-Hoang, T., Carstens, J. L., Zheng, X., Wu, C.-C., Simpson, T. R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S. V., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.005 · Cited by 2,681 · cited 1×
“As shown by both experimental [22,23] and clinical [13] studies, stromal depletion results in more aggressive disease and impaired patient outcomes.”
BackgroundCD44 is the principal cell surface receptor for hyaluronate
Aruffo, A., Stamenkovic, I., Melnick, M., Underhill, C. B., & Seed, B. (1990) · Cell · doi:10.1016/0092-8674(90)90694-a · Cited by 2,438
Ricard-Blum, S. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004978 · Cited by 2,305
Provenzano, P. P., Cuevas, C., Chang, A. E., Goel, V. K., Von Hoff, D. D., & Hingorani, S. R. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.01.007 · Cited by 2,195 · cited 4×
“First occurring in pre-neoplastic pancreatic intraepithelial neoplasia (PanIN) lesions, HA is expressed in abundant amounts in the ECM [123] and following application of PEGPH20, an HA-degrading enzyme, intratumoral tissue pressure is decreased in PDAC mouse models (Pdx1-Cre;KrasG12D;Trp53R172H) [125,126].”
BackgroundInfluentialMechanotransduction and extracellular matrix homeostasis
Humphrey, J. D., Dufresne, E. R., & Schwartz, M. A. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3896 · Cited by 2,124
Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma
Rhim, A. D., Oberstein, P. E., Thomas, D. H., Mirek, E. T., Palermo, C. F., Sastra, S. A., Dekleva, E. N., Saunders, T., Becerra, C. P., Tattersall, I. W., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.021 · Cited by 2,085
Hyaluronan: its nature, distribution, functions and turnover.
Fraser, J. R. E., Laurent, T. C., & Laurent, U. B. G. (1997) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1997.00170.x · Cited by 2,031 · cited 2×
“character of the interstitial fluid [124].”
BackgroundThe extracellular matrix modulates the hallmarks of cancer
Pickup, M. W., Mouw, J. K., & Weaver, V. M. (2014) · EMBO reports · doi:10.15252/embr.201439246 · Cited by 1,996
The Biology of YAP/TAZ: Hippo Signaling and Beyond
Piccolo, S., Dupont, S., & Cordenonsi, M. (2014) · Physiological Reviews · doi:10.1152/physrev.00005.2014 · Cited by 1,802
Basement membranes: structure, assembly and role in tumour angiogenesis
Kalluri, R. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1094 · Cited by 1,748
Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells
Commisso, C., Davidson, S. M., Soydaner-Azeloglu, R. G., Parker, S. J., Kamphorst, J. J., Hackett, S., Grabocka, E., Nofal, M., Drebin, J. A., Thompson, C. B., et al. (2013) · Nature · doi:10.1038/nature12138 · Cited by 1,683
Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis
Thayer, S. P., di Magliano, M. P., Heiser, P. W., Nielsen, C. M., Roberts, D. J., Lauwers, G. Y., Qi, Y. P., Gysin, S., Castillo, C. F.-D., Yajnik, V., et al. (2003) · Nature · doi:10.1038/nature02009 · Cited by 1,480
A causal role for E-cadherin in the transition from adenoma to carcinoma
Perl, A.-K., Wilgenbus, P., Dahl, U., Semb, H., & Christofori, G. (1998) · Nature · doi:10.1038/32433 · Cited by 1,424
Naba, A., Clauser, K. R., Hoersch, S., Liu, H., Carr, S. A., & Hynes, R. O. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.014647 · Cited by 1,354
Sherman, M. H., Yu, R. T., Engle, D. D., Ding, N., Atkins, A. R., Tiriac, H., Collisson, E. A., Connor, F., Van Dyke, T., Kozlov, S., et al. (2014) · Cell · doi:10.1016/j.cell.2014.08.007 · Cited by 1,158
Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer
Jacobetz, M. A., Chan, D. S., Neesse, A., Bapiro, T. E., Cook, N., Frese, K. K., Feig, C., Nakagawa, T., Caldwell, M. E., Zecchini, H. I., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-302529 · Cited by 1,120
CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?
Zöller, M. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3023 · Cited by 1,112
Chauhan, V. P., Martin, J. D., Liu, H., Lacorre, D. A., Jain, S. R., Kozin, S. V., Stylianopoulos, T., Mousa, A. S., Han, X., Adstamongkonkul, P., et al. (2013) · Nature Communications · doi:10.1038/ncomms3516 · Cited by 1,031 · cited 3×
“In addition to PEGPH20, HA may also be targeted using angiotensin inhibitors, which have been shown to reduce stromal HA and collagen production [134].”
BackgroundKamphorst, J. J., Nofal, M., Commisso, C., Hackett, S. R., Lu, W., Grabocka, E., Vander Heiden, M. G., Miller, G., Drebin, J. A., Bar-Sagi, D., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2211 · Cited by 893
Induction of Membrane Ruffling and Fluid-Phase Pinocytosis in Quiescent Fibroblasts by ras Proteins
Bar-Sagi, D., & Feramisco, J. R. (1986) · Science · doi:10.1126/science.3090687 · Cited by 734 · cited 1×
“KRAS-mutant PDAC cells (>90%) are characterized by membrane ruffling, which enables the PDAC cells to form macropinosomes, large vacuoles that may non-specifically take up extracellular molecules and transfer them to lysosomes for degradation [97,98].”
BackgroundHotary, K. B., Allen, E. D., Brooks, P. C., Datta, N. S., Long, M. W., & Weiss, S. J. (2003) · Cell · doi:10.1016/s0092-8674(03)00513-0 · Cited by 676
Bachem, M. G., Schünemann, M., Ramadani, M., Siech, M., Beger, H., Buck, A., Zhou, S., Schmid-Kotsas, A., & Adler, G. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.12.036 · Cited by 657
Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic Cancer
Whatcott, C. J., Diep, C. H., Jiang, P., Watanabe, A., LoBello, J., Sima, C., Hostetter, G., Shepard, H. M., Von Hoff, D. D., & Han, H. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1051 · Cited by 645
Laklai, H., Miroshnikova, Y. A., Pickup, M. W., Collisson, E. A., Kim, G. E., Barrett, A. S., Hill, R. C., Lakins, J. N., Schlaepfer, D. D., Mouw, J. K., et al. (2016) · Nature Medicine · doi:10.1038/nm.4082 · Cited by 603
Desmoplastic Reaction in Pancreatic Cancer: Role of Pancreatic Stellate Cells
Apte, M. V., Park, S., Phillips, P. A., Santucci, N., Goldstein, D., Kumar, R. K., Ramm, G. A., Buchler, M., Friess, H., McCarroll, J. A., et al. (2004) · Pancreas · doi:10.1097/00006676-200410000-00002 · Cited by 591 · cited 3×
“Once PSCs become activated, however, the equilibrium shifts, causing the accumulation of large amounts of ECM proteins [11,13].”
BackgroundLOX-Mediated Collagen Crosslinking Is Responsible for Fibrosis-Enhanced Metastasis
Cox, T. R., Bird, D., Baker, A.-M., Barker, H. E., Ho, M. W.-Y., Lang, G., & Erler, J. T. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2233 · Cited by 571
Bataller, R., Schwabe, R. F., Choi, Y. H., Yang, L., Paik, Y. H., Lindquist, J., Qian, T., Schoonhoven, R., Hagedorn, C. H., Lemasters, J. J., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18212 · Cited by 548
Rice, A. J., Cortes, E., Lachowski, D., Cheung, B. C. H., Karim, S. A., Morton, J. P., & del Río Hernández, A. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.54 · Cited by 523
Sonic Hedgehog Promotes Desmoplasia in Pancreatic Cancer
Bailey, J. M., Swanson, B. J., Hamada, T., Eggers, J. P., Singh, P. K., Caffery, T., Ouellette, M. M., & Hollingsworth, M. A. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0291 · Cited by 519
Hingorani, S. R., Zheng, L., Bullock, A. J., Seery, T. E., Harris, W. P., Sigal, D. S., Braiteh, F., Ritch, P. S., Zalupski, M. M., Bahary, N., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.9564 · Cited by 510
The good and the bad collagens of fibrosis – Their role in signaling and organ function
Karsdal, M. A., Nielsen, S. H., Leeming, D. J., Langholm, L. L., Nielsen, M. J., Manon-Jensen, T., Siebuhr, A., Gudmann, N. S., Rønnow, S., Sand, J. M., et al. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.07.014 · Cited by 509
Stromal response to Hedgehog signaling restrains pancreatic cancer progression
Lee, J. J., Perera, R. M., Wang, H., Wu, D.-C., Liu, X. S., Han, S., Fitamant, J., Jones, P. D., Ghanta, K. S., Kawano, S., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1411679111 · Cited by 502
Extracellular Matrix Degradation and the Role of Hepatic Stellate Cells
Benyon, R. C., & Arthur, M. J. P. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-17552 · Cited by 485
More deaths from pancreatic cancer than breast cancer in the EU by 2017
Ferlay, J., Partensky, C., & Bray, F. (2016) · Acta Oncologica · doi:10.1080/0284186x.2016.1197419 · Cited by 466
CD44 in Cancer Progression: Adhesion, Migration and Growth Regulation
Marhaba, R., & Zöller, M. (2004) · Journal of Molecular Histology · doi:10.1023/b:hijo.0000032354.94213.69 · Cited by 438
N-Cadherin Expression and Epithelial-Mesenchymal Transition in Pancreatic Carcinoma
Nakajima, S., Doi, R., Toyoda, E., Tsuji, S., Wada, M., Koizumi, M., Tulachan, S. S., Ito, D., Kami, K., Mori, T., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0578-03 · Cited by 427
Olivares, O., Mayers, J. R., Gouirand, V., Torrence, M. E., Gicquel, T., Borge, L., Lac, S., Roques, J., Lavaut, M.-N., Berthezène, P., et al. (2017) · Nature Communications · doi:10.1038/ncomms16031 · Cited by 413 · cited 2×
“Since the ECM serves as a source of glucose and amino acids for PDAC cells under the meager conditions of the desmoplastic reaction, targeting macropinocytosis might block the ECM as a nutritional supply for PDAC [45].”
BackgroundInfante, J. R., Matsubayashi, H., Sato, N., Tonascia, J., Klein, A. P., Riall, T. A., Yeo, C., Iacobuzio-Donahue, C., & Goggins, M. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.8824 · Cited by 406
Turashvili, G., Bouchal, J., Baumforth, K., Wei, W., Dziechciarkova, M., Ehrmann, J., Klein, J., Fridman, E., Skarda, J., Srovnal, J., et al. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-55 · Cited by 385
Discoidin domain receptor tyrosine kinases: new players in cancer progression
Valiathan, R. R., Marco, M., Leitinger, B., Kleer, C. G., & Fridman, R. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9346-z · Cited by 383
The Ehlers–Danlos syndrome, a disorder with many faces
De Paepe, A., & Malfait, F. (2012) · Clinical Genetics · doi:10.1111/j.1399-0004.2012.01858.x · Cited by 379 · cited 2×
“presentation of this disease, mutations in procollagen V (COL5A1/COL5A2) prevent the assembly of collagen I and V heterotrimers, resulting in joint hypermobility, skin hyperextensibility, and widened atrophic scars [35].”
BackgroundWolpin, B. M., Rubinson, D. A., Wang, X., Chan, J. A., Cleary, J. M., Enzinger, P. C., Fuchs, C. S., McCleary, N. J., Meyerhardt, J. A., Ng, K., et al. (2014) · The Oncologist · doi:10.1634/theoncologist.2014-0086 · Cited by 374
Hingorani, S. R., Harris, W. P., Beck, J. T., Berdov, B. A., Wagner, S. A., Pshevlotsky, E. M., Tjulandin, S. A., Gladkov, O. A., Holcombe, R. F., Korn, R., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2010 · Cited by 333
Löhr, M. J., Schmidt, C., Ringel, J., Kluth, M., Müller, P., Nizze, H., & Jesnowski, R. (2001) · PubMed · Cited by 325
Pancreatic stellate cells: a starring role in normal and diseased pancreas
Apte, M. V., Pirola, R. C., & Wilson, J. S. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00344 · Cited by 322
Type I Collagen Promotes the Malignant Phenotype of Pancreatic Ductal Adenocarcinoma
Armstrong, T., Packham, G., Murphy, L. B., Bateman, A. C., Conti, J. A., Fine, D. R., Johnson, C. D., Benyon, R. C., & Iredale, J. P. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0825 · Cited by 317
Dallas, S. L., Sivakumar, P., Jones, C. J. P., Chen, Q., Peters, D. M., Mosher, D. F., Humphries, M. J., & Kielty, C. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410762200 · Cited by 316
Rho‐associated kinases in tumorigenesis: re‐considering ROCK inhibition for cancer therapy
Rath, N., & Olson, M. F. (2012) · EMBO reports · doi:10.1038/embor.2012.127 · Cited by 302
Enzymatic Depletion of Tumor Hyaluronan Induces Antitumor Responses in Preclinical Animal Models
Thompson, C. B., Shepard, H. M., O'Connor, P. M., Kadhim, S., Jiang, P., Osgood, R. J., Bookbinder, L. H., Li, X., Sugarman, B. J., Connor, R. J., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0470 · Cited by 298
Phillips, P. A. (2003) · Gut · doi:10.1136/gut.52.2.275 · Cited by 295
Shi, Q., Abbruzzese, J. L., Huang, S., Fidler, I. J., Xiong, Q., & Xie, K. (1999) · PubMed · Cited by 293
Shek, F. W.-T., Benyon, R. C., Walker, F. M., McCrudden, P. R., Pender, S. L. F., Williams, E. J., Johnson, P. A., Johnson, C. D., Bateman, A. C., Fine, D. R., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61125-x · Cited by 288
Miller, B. W., Morton, J. P., Pinese, M., Saturno, G., Jamieson, N. B., McGhee, E., Timpson, P., Leach, J., McGarry, L., Shanks, E., et al. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404827 · Cited by 286
Koenig, A., Mueller, C., Hasel, C., Adler, G., & Menke, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2804 · Cited by 277
Chronopoulos, A., Robinson, B., Sarper, M., Cortes, E., Auernheimer, V., Lachowski, D., Attwood, S., García, R., Ghassemi, S., Fabry, B., et al. (2016) · Nature Communications · doi:10.1038/ncomms12630 · Cited by 274
Sato, N., Fukushima, N., Maehara, N., Matsubayashi, H., Koopmann, J., Su, G. H., Hruban, R. H., & Goggins, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206807 · Cited by 273
Qazi, B. S., Tang, K., & Qazi, A. (2011) · International Journal of Inflammation · doi:10.4061/2011/908468 · Cited by 272
Shintani, Y., Fukumoto, Y., Chaika, N., Svoboda, R., Wheelock, M. J., & Johnson, K. R. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200708137 · Cited by 267
Selective Binding of Collagen Subtypes by Integrin α1I, α2I, and α10I Domains
Tulla, M., Pentikäinen, O. T., Viitasalo, T., Käpylä, J., Impola, U., Nykvist, P., Nissinen, L., Johnson, M. S., & Heino, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104058200 · Cited by 256
Gao, H., Chakraborty, G., Zhang, Z., Akalay, I., Gadiya, M., Gao, Y., Sinha, S., Hu, J., Jiang, C., Akram, M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.06.009 · Cited by 246
Miyamoto, H., Murakami, T., Tsuchida, K., Sugino, H., Miyake, H., & Tashiro, S. (2004) · Pancreas · doi:10.1097/00006676-200401000-00006 · Cited by 239
Boone, B. A., Bahary, N., Zureikat, A. H., Moser, A. J., Normolle, D. P., Wu, W.-C., Singhi, A. D., Bao, P., Bartlett, D. L., Liotta, L. A., et al. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4566-4 · Cited by 234 · cited 1×
“Here HQ reduced CA19-9 in resectable patients [149], but patients with metastatic disease did not show any significant therapeutic efficacy [150].”
BackgroundUnraveling galectin-1 as a novel therapeutic target for cancer
Astorgues-Xerri, L., Riveiro, M. E., Tijeras-Raballand, A., Serova, M., Neuzillet, C., Albert, S., Raymond, E., & Faivre, S. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.07.007 · Cited by 226
Overview of Extracellular Matrix
Mecham, R. P. (2012) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb1001s57 · Cited by 211
Menke, A., Philippi, C., Vogelmann, R., Seidel, B., Lutz, M. P., Adler, G., & Wedlich, D. (2001) · PubMed · Cited by 196
Öhlund, D., Franklin, O., Lundberg, E., Lundin, C., & Sund, M. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-154 · Cited by 189
Lumican, a small leucine‐rich proteoglycan
Nikitovic, D., Katonis, P., Tsatsakis, A. M., Karamanos, N. K., & Tzanakakis, G. N. (2008) · IUBMB Life · doi:10.1002/iub.131 · Cited by 179
Dangi-Garimella, S., Krantz, S. B., Barron, M. R., Shields, M. A., Heiferman, M. J., Grippo, P. J., Bentrem, D. J., & Munshi, H. G. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1855 · Cited by 176
Nakai, Y., Isayama, H., Ijichi, H., Sasaki, T., Sasahira, N., Hirano, K., Kogure, H., Kawakubo, K., Yagioka, H., Yashima, Y., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605955 · Cited by 172
Tissue transglutaminase in normal and abnormal wound healing: Review article
Verderio, E. A. M., Johnson, T., & Griffin, M. (2004) · Amino Acids · doi:10.1007/s00726-004-0094-4 · Cited by 171
Theocharis, A. D., Tsara, M. E., Papageorgacopoulou, N., Karavias, D. D., & Theocharis, D. A. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00051-x · Cited by 169
Edderkaoui, M., Hong, P., Vaquero, E. C., Lee, J. K., Fischer, L., Friess, H., Büchler, M. W., Lerch, M. M., Pandol, S. J., & Gukovskaya, A. S. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00197.2005 · Cited by 164
Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor–stroma crosstalk
Orozco, C. A., Martinez-Bosch, N., Guerrero, P. E., Vinaixa, J., Dalotto-Moreno, T., Iglesias, M., Moreno, M., Djurec, M., Poirier, F., Gabius, H.-J., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1722434115 · Cited by 158
Basement membranes and human disease
Agtmael, T. V., & Bruckner‐Tuderman, L. (2009) · Cell and Tissue Research · doi:10.1007/s00441-009-0866-y · Cited by 156
Matricellular Proteins: A Sticky Affair with Cancers
Chong, H. C., Tan, C. K., Huang, R.-L., & Tan, N. S. (2012) · Journal of Oncology · doi:10.1155/2012/351089 · Cited by 156
Naba, A., Clauser, K. R., & Hynes, R. O. (2015) · Journal of Visualized Experiments · doi:10.3791/53057 · Cited by 153
Mollenhauer, J. A., Roether, I., & Kern, H. F. (1987) · Pancreas · doi:10.1097/00006676-198701000-00003 · Cited by 147
Neeße, A., Frese, K. K., Chan, D. S., Bapiro, T. E., Howat, W., Richards, F. M., Ellenrieder, V., Jodrell, D. I., & Tuveson, D. A. (2013) · Gut · doi:10.1136/gutjnl-2013-305559 · Cited by 147
Overview of Extracellular Matrix
Mecham, R. P. (1998) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb1001s00 · Cited by 144
Hidalgo, M. M., Plaza, C., Musteanu, M., Illei, P. B., Brachmann, C. B., Heise, C. C., Pierce, D. W., Lopez-Casas, P. P., Menéndez, C., Tabernero, J. M., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-3222 · Cited by 141
Conroy, T., Hammel, P. R., Hebbar, M., Abdelghani, M. B., Wei, A. C.-C., Raoul, J., Choné, L., François, É., Artru, P., Biagi, J. J., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.36.18_suppl.lba4001 · Cited by 140
Rath, N., Morton, J. P., Julian, L., Helbig, L., Kadir, S. R., McGhee, E. J., Anderson, K. I., Kalna, G., Mullin, M., Pinho, A. V., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606743 · Cited by 137
Haage, A., & Schneider, I. C. (2014) · The FASEB Journal · doi:10.1096/fj.13-245613 · Cited by 133
Type IV collagen is a tumour stroma-derived biomarker for pancreas cancer
Öhlund, D., Lundin, C., Ardnor, B., Öman, M., Naredi, P. L. J., & Sund, M. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605107 · Cited by 132
Matrikines from basement membrane collagens: A new anti-cancer strategy
Monboisse, J., Oudart, J., Ramont, L., Brassart‐Pasco, S., & Maquart, F. X. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.12.029 · Cited by 129
Aguilera, K. Y., Huang, H., Du, W., Hagopian, M. M., Wang, Z., Hinz, S., Hwang, T. H., Wang, H., Fleming, J. B., Castrillon, D. H., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0834 · Cited by 118 · cited 2×
“DDR1 was effectively inhibited by the orally available small molecule kinase inhibitor 7rh, resulting in decreased tumor burden and improved response to concomitant chemotherapy in xenograft and genetically engineered mouse models of PDAC [68].”
BackgroundMartínez‐Bosch, N., Fernández‐Barrena, M. G., Moreno, M., Zapater, E. O., Munné‐Collado, J., Iglesias, M., André, S., Gabius, H., Hwang, R. F., Poirier, F., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3013 · Cited by 115
Imamura, T., Iguchi, H., Manabe, T., Ohshio, G., Yoshimura, T., Wang, Z.-H., Suwa, H., Ishigami, S., & Imamura, M. (1995) · Pancreas · doi:10.1097/00006676-199511000-00007 · Cited by 109
Pan, S., Chen, R., Tamura, Y., Crispin, D. A., Lai, L. A., May, D., McIntosh, M. W., Goodlett, D. R., & Brentnall, T. A. (2014) · Journal of Proteome Research · doi:10.1021/pr4010184 · Cited by 107
Lung cancer risk among patients with combined pulmonary fibrosis and emphysema
Kwak, N., Park, C. M., Lee, J., Park, Y. S., Lee, S., Yim, J., Yoo, C., Kim, Y. W., Han, S., & Lee, C. (2014) · Respiratory Medicine · doi:10.1016/j.rmed.2013.11.013 · Cited by 106
Grzesiak, J. J., Cao, H. S. T., Burton, D. W., Kaushal, S., Vargas, F., Clopton, P., Snyder, C. S., Deftos, L. J., Hoffman, R. M., & Bouvet, M. (2011) · International Journal of Cancer · doi:10.1002/ijc.25942 · Cited by 105
Ottaviano, A. J., Sun, L., Ananthanarayanan, V., & Munshi, H. G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4421 · Cited by 105
Tissue Transglutaminase Mediated Tumor–Stroma Interaction Promotes Pancreatic Cancer Progression
Lee, J., Condello, S., Yakubov, B., Emerson, R. E., Caperell–Grant, A., Hitomi, K., Xie, J., & Matei, D. E. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0226 · Cited by 105
Fendrich, V., Chen, N., Neef, M., Waldmann, J., Buchholz, M., Feldmann, G., Slater, E. P., Maitra, A., & Bartsch, D. K. (2009) · Gut · doi:10.1136/gut.2009.188961 · Cited by 104
Antibodies to SPARC inhibit albumin binding to SPARC, gp60, and microvascular endothelium
Schnitzer, J. E., & Oh, P. (1992) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1992.263.6.h1872 · Cited by 102
Rho kinase inhibitors block activation of pancreatic stellate cells
Masamune, A., Kikuta, K., Satoh, M., Satoh, K., & Shimosegawa, T. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705551 · Cited by 100
Human ductal adenocarcinomas of the pancreas express extracellular matrix proteins
Löhr, M. J., Trautmann, B., Göttler, M., Peters, S., Zauner, I., Maillet, B., & Klöppel, G. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.24 · Cited by 99
Linder, S., Castaños‐Vélez, E., von Rosen, A., & Biberfeld, P. (2001) · PubMed · Cited by 99
Begum, A., Ewachiw, T. E., Jung, C., Huang, A., Norberg, K. J., Marchionni, L., McMillan, R. H., Penchev, V. R., Rajeshkumar, N. V., Maitra, A., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180181 · Cited by 95
Collagen type V promotes the malignant phenotype of pancreatic ductal adenocarcinoma
Berchtold, S., Grünwald, B. T., Krüger, A., Reithmeier, A., Hähl, T., Cheng, T., Feuchtinger, A., Born, D., Erkan, M., Kleeff, J. H., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.10.020 · Cited by 94
Li, X., Truty, M. A., Kang, Y., Chopin‐Laly, X., Zhang, R., Roife, D., Chatterjee, D., Lin, E. H., Thomas, R. M., Wang, H., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0970 · Cited by 92
Molecular composition and function of integrin-based collagen glues—Introducing COLINBRIs
Zeltz, C., Orgel, J. P. R. O., & Gullberg, D. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.12.022 · Cited by 89
Amenta, P. S., Hadad, S., Lee, M. T., Barnard, N., Li, D., & Myers, J. C. (2003) · The Journal of Pathology · doi:10.1002/path.1303 · Cited by 85
Dangi-Garimella, S. Y., Sahai, V., Ebine, K., Kumar, K., & Munshi, H. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064566 · Cited by 83
Promotion of Tumor Cell Migration by Extracellular Matrix Proteins in Human Pancreatic Cancer
Ryschich, E., Khamidjanov, A., Kerkadze, V., Büchler, M. W., Zöller, M., & Schmidt, J. (2009) · Pancreas · doi:10.1097/mpa.0b013e3181b9dfda · Cited by 81
Sinn, M., Sinn, B. V., Striefler, J. K., Lindner, J., Stieler, J., Lohneis, P., Bischoff, S., Bläker, H., Pelzer, U., Bahra, M., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu084 · Cited by 77
Huang, H., Svoboda, R. A., Lazenby, A. J., Saowapa, J., Chaika, N. V., Ding, K., Wheelock, M. J., & Johnson, K. R. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.740605 · Cited by 74
Hyaluronan stimulates pancreatic cancer cell motility
Cheng, X., Kohi, S., Koga, A., Hirata, K., & Sato, N. (2015) · Oncotarget · doi:10.18632/oncotarget.6617 · Cited by 73
Park, Y. R., Lee, S. T., Kim, S., Liu, Y. C., Lee, M. R., Shin, J. H., Seo, S. Y., Kim, S., Kim, I. H., Lee, S. O., et al. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3430 · Cited by 71
Glycoproteins and glycoproteomics in pancreatic cancer
Pan, S., Brentnall, T. A., & Chen, R. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i42.9288 · Cited by 70
D’Costa, Z., Jones, K. I., Azad, A. K., van Stiphout, R. G. P. M., Lim, S. Y., Gomes, A. L., Kinchesh, P., Smart, S., McKenna, W. G., Buffa, F. M., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2833 · Cited by 69
Lü, J., Zhou, S., Siech, M., Habisch, H., Seufferlein, T. T. W., & Bachem, M. G. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.706 · Cited by 65
Vascular smooth muscle cells in Marfan syndrome aneurysm: the broken bricks in the aortic wall
Perrucci, G. L., Rurali, E., Gowran, A., Pini, A., Antona, C., Chiesa, R., Pompilio, G., & Nigro, P. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2324-9 · Cited by 65
TM4SF1 Promotes Proliferation, Invasion, and Metastasis in Human Liver Cancer Cells
Huang, Y.-K., Fan, X., & Qiu, F. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050661 · Cited by 64
Stromal Depletion Goes on Trial in Pancreatic Cancer
Garber, K. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq113 · Cited by 63
Li, Z., Jia, Z., Gao, Y., Xie, D., Wei, D., Cui, J., Mishra, L., Huang, S., Zhang, Y., & Xie, K. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2437 · Cited by 63
Chen, R., Pan, S., Ottenhof, N. A., de Wilde, R. F., Wolfgang, C. L., Lane, Z., Post, J., Bronner, M. P., Willmann, J. K., Maitra, A., et al. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.20842 · Cited by 62
TM4SF1 Promotes Metastasis of Pancreatic Cancer via Regulating the Expression of DDR1
Yang, J.-C., Zhang, Y., He, S., Li, M., Cai, X., Wang, H., Xu, L., & Cao, J. (2017) · Scientific Reports · doi:10.1038/srep45895 · Cited by 61
Chen, R., Dawson, D. W., Pan, S., Ottenhof, N. A., de Wilde, R. F., Wolfgang, C. L., May, D. H., Crispin, D. A., Lai, L. A., Lay, A. R., et al. (2015) · Laboratory Investigation · doi:10.1038/labinvest.2014.128 · Cited by 59 · cited 1×
“Additionally, both N-glycosylation [102] and expression of the core proteins of periostin [102], fibulin 1 [102], and galectin 1 [103] have been found to be upregulated in PDAC [104,105].”
Quantitative proteomics investigation of pancreatic intraepithelial neoplasia
Pan, S., Chen, R., Reimel, B. A., Crispin, D. A., Mirzaei, H., Cooke, K., Coleman, J. F., Lane, Z., Bronner, M. P., Goodlett, D. R., et al. (2009) · Electrophoresis · doi:10.1002/elps.200800752 · Cited by 59
Patsenker, E., Popov, Y. V., Wiesner, M., Goodman, S. L., & Schuppan, D. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.11.011 · Cited by 58
Structural requirements for α1β1 and α2β1 integrin mediated cell adhesion to collagen V
Ruggiero, F., Comte, J., Cabañas, C., & Garrone, R. (1996) · Journal of Cell Science · doi:10.1242/jcs.109.7.1865 · Cited by 57
Collagen XV Inhibits Epithelial to Mesenchymal Transition in Pancreatic Adenocarcinoma Cells
Clementz, A. G., Mutolo, M. J., Leir, S., Morris, K. J., Kucybala, K., Harris, H., & Harris, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072250 · Cited by 53
Cheng, X., Sato, N., Kohi, S., Koga, A., & Hirata, K. (2015) · Journal of Cancer · doi:10.7150/jca.12990 · Cited by 52
Role of α5β1 Integrin Up-regulation in Radiation-Induced Invasion by Human Pancreatic Cancer Cells
Yao, H., Zeng, Z.-Z., Fay, K. S., Veine, D. M., Staszewski, E. D., Morgan, M. A., Wilder-Romans, K., Williams, T. M., Spalding, A. C., Ben‐Josef, E., et al. (2011) · Translational Oncology · doi:10.1593/tlo.11133 · Cited by 49
Prolonged exposure to extracellular lumican restrains pancreatic adenocarcinoma growth
Li, X., Kang, Y., Roife, D., Lee, Y., Pratt, M. F., Perez, M. V. R., Dai, B., Koay, E. J., & Fleming, J. B. (2017) · Oncogene · doi:10.1038/onc.2017.125 · Cited by 48
Grzesiak, J. J., & Bouvet, M. (2007) · Pancreas · doi:10.1097/01.mpa.0000250129.64650.f6 · Cited by 43
TM4SF1 Regulates Pancreatic Cancer Migration and Invasion In Vitro and In Vivo
Cao, J., Yang, J.-C., Ramachandran, V., Arumugam, T., Deng, D.-F., Li, Z.-S., Xu, L.-M., & Logsdon, C. D. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000445664 · Cited by 42
Involvement of Angiotensin II and Reactive Oxygen Species in Pancreatic Fibrosis
Sakurai, T., Kudo, M., Fukuta, N., Nakatani, T., Kimura, M., Park, A.-M., & Munakata, H. (2011) · Pancreatology · doi:10.1159/000323478 · Cited by 37
Sun, Y., Xu, Y., Xu, J., Lü, D., & Wang, J. (2015) · PubMed Central · Cited by 37
Nakai, Y., Isayama, H., Sasaki, T., Takahara, N., Saito, K., Ishigaki, K., Hamada, T., Mizuno, S., Miyabayashi, K., Yamamoto, K., et al. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1873-2 · Cited by 31
Kohi, S., Sato, N., Koga, A., Hirata, K., Harunari, E., & Igarashi, Y. (2016) · Journal of Oncology · doi:10.1155/2016/9063087 · Cited by 29
Cited by
Extracellular matrix and its therapeutic potential for cancer treatment
Huang, J., Zhang, L., Wan, D., Zhou, L., Zheng, S., Lin, S., & Qiao, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00544-0 · Cited by 962
Cellular mechanotransduction in health and diseases: from molecular mechanism to therapeutic targets
Di, X., Gao, X., Peng, L., Ai, J., Jin, X., Qi, S., Li, H., Wang, K., & Luo, D. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01501-9 · Cited by 622
Van Cutsem, E., Tempero, M. A., Sigal, D., Oh, D.-Y., Fazio, N., Macarulla, T., Hitre, E., Hammel, P., Hendifar, A. E., Bates, S. E., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.00590 · Cited by 499
Obstacles and opportunities in a forward vision for cancer nanomedicine
de Lázaro, I., & Mooney, D. J. (2021) · Nature Materials · doi:10.1038/s41563-021-01047-7 · Cited by 439
Hosein, A. N., Huang, H., Wang, Z., Parmar, K., Du, W., Huang, J., Maitra, A., Olson, E., Verma, U., & Brekken, R. A. (2019) · JCI Insight · doi:10.1172/jci.insight.129212 · Cited by 302
Metadata
- Authors
- Weniger, M., Honselmann, K., & Liss, A.
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2018-09-06
- Volume
- 10
- Issue
- 9
- Pages
- 316
- ISSN
- 2072-6694 (ISSN-L)
- OpenAlex
- W2889990912
- Cited by
- 268
- References
- 150
- FWCI
- 11.37
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.